Technology | January 31, 2011

Invivo - DynaTrim MRI Prostate Biopsy Device Increases Patient Comfort

DynaCAD for prostate and DynaTRIM, both part of Invivo’s Prostate Clinical Solution, give physicians the tools to perform real-time analysis of prostate magnetic resonance imaging (MRI) studies and the support for an MRI-guided prostate biopsy. The device was showcased at RSNA 2010.

DynaTRIM is a fully MR-compatible interventional device for transrectal interventional MR biopsy of the prostate gland. It is a removable device that is designed to affix to an imaging table to an open design that allows for flexibility in coil choice and a cleanable foam pad for extra patient comfort. The DynaTRIM needle guide is smaller than the endorectal probe used for traditional transrectal ultrasound (TRUS) biopsies, so it usually is better tolerated by patients.

Invivo also has recently made an agreement with CorTechs Labs to be the key distributor for the NeuroQuant product in the U.S. marketplace. NeuroQuant will augment Invivo’s DynaSuite Neuro Solution by providing enhanced diagnostic capabilities to healthcare practitioners that may help in the assessment of patients with Alzheimer’s, epilepsy and other neurological disorders.

DynaSuite Neuro is an MR neuro solution designed for optimal workflow and repeatable analysis for pediatrics and adults. The data is automatically processed and displayed in predefined layouts, which are customizable for the physician’s preference. The simplified user interface provides the neuroradiologist with the tools to analyze perfusion (PWI), diffusion (DWI) and functional MRI (fMRI) quickly and easily.

DynaSuite Neuro is compatible with all major MRI systems. Data sets from the MR system are automatically sent to DynaSuite Neuro, processed in the background and registered to a high resolution 3-D T1. In each review screen, images are synchronized for easy viewing and correlation.

DynaSuite Neuro is designed to streamline workflow through automated processes. Registration, vessel, skull stripping, diffusion and fMRI QC applications facilitate a visual inspection of results and making adjustments to positioning or thresholds. DynaSuite Neuro also has the ability to create a “results image series” and a final report. The results images as well as the report can be sent to a PACS system and automatically combined with the original study data. The report is converted to a DICOM file and can be viewed with the images. The results images can also be exported to a surgical planning system.

Related Content

"Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4-15 brain metastases: A phase III randomized controlled trial" was presented by Jing Li, M.D., The University of Texas MD Anderson Cancer Center, at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
October 26, 2020 — Results of a new randomized phase III trial suggest that...
"Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial," presented by Shankar Siva, Ph.D., Peter MacCallum Cancer Centre, was presented at ASTRO20
News | Stereotactic Body Radiation Therapy (SBRT) | October 26, 2020
October 26, 2020 — A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the cas
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging | October 26, 2020
October 26, 2020 — Adding the advanced PET radiotracer...
A randomized phase II/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases was presented by Arjun Sahgal, M.D., University of Toronto, today at ASTRO20
News | Radiation Therapy | October 26, 2020
October 26, 2020 — A new study shows using fewer and higher doses of high-precision...
Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
Nearly 40 MRIdian-focused presentations will be part of the ASTRO Scientific Sessions
News | Magnetic Resonance Imaging (MRI) | October 26, 2020
October 26, 2020 — ViewRay, Inc. announced that the company's MRIdian Linac MRI-guided radiation therapy system will
Treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases, suggests a new study from Penn Medicine. In a retrospective trial of more than 200 patients, mini-strokes were significantly less common among patients who underwent proton therapy versus conventional photon-based radiation therapy. Proton therapy patients also experienced fewer heart attacks.
News | Proton Therapy | October 25, 2020
October 25, 2020 — Treating lung cancer patients with prot...
Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management can reduce the time from patient referral to the start of treatment by up to half
News | Radiation Oncology | October 25, 2020
October 25, 2020 —Philips, a global leader in health technology, will showcase its latest advances in ...